Francisco F. Nogales
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Francisco F. Nogales has a total of 88 co-authors. Here are the top co-authors by number of shared publications:
Maolly Schuldt
Department of Pathology, University of Granada, Granada, Spain
7 shared publicationsOvidiu Preda
Master Diagnostica SL
7 shared publicationsIsabel Dulcey
Departments of Pathology San Cecilio University Hospital Granada Spain
5 shared publications- Enoe Quiñonez
Department of Pathology, Facultad de Medicina, San Cecilio University of Granada Hospital, Granada, Spain
3 shared publications A Zuluaga
Department of Urology, University Hospital, Granada, Spain
2 shared publicationsAlejandro Rubio
Department of Pathology, San Cecilio University Hospital, Granada, Spain
2 shared publications
Latest Publications
- 6 November 2017
- Published by Wiley in Histopathology
- Vol. 72 (4) , 634-647
Germ cell tumour growth patterns originating from clear cell carcinomas of the ovary and endometrium: a comparative immunohistochemical study favouring their origin from somatic stem cells
Aims: To report a series of 11 ovarian and one endometrial neoplasm in elderly patients with mixed clear cell tumour and germ cell tumour (GCT) components, to compare their immunohistochemical profiles and demonstrate a putative stem cell population.Methods and results: The clear cell tumours included 11 clear cell carcinomas (CCC) and one borderline clear cell tumour, while the GCT always included glandular yolk sac tumour (YST). In four cases, there were also foci of teratoma with immature neuroepithelial and endodermal tissues and undifferentiated areas showing true embryoids. To distinguish between the clear cell and YST components, the following antibodies were used: HNF1‐β, napsin‐A, cytokeratin 7 (CK7), PAX8, EMA, AFP, SALL4, villin, glypican‐3 (GPC‐3), GATA3, HepPar‐1, OCT4, CDX2, CD30 and SOX2. HNF1‐β, CK7, EMA and GPC‐3 were often expressed in both components. Other markers had higher specificity for each cellular lineage; napsin‐A and PAX8 were expressed only in CCC, while SALL4, villin, AFP and HepPar‐1 were positive in the glandular YST component but negative in the clear cell component. OCT4 expression occurred in six of 10 cases and consistently in teratoma (four of four).Conclusions: There is considerable immunophenotypical overlap between the two components in these mixed neoplasms, and a panel of markers should be used to facilitate the distinction. We propose that OCT4‐expressing somatic cancer cells differentiate into GCT and represent spontaneously induced pluripotent stem cells, possibly conditioned by age‐related epigenetic factors. These neoplasms have features of prepubertal type GCT showing lack of 12p gain, preponderance of YST and coexistence with immature neuroectoderm. However, there may also be undifferentiated stem cell areas with embryoid bodies, of the type seen in postpubertal testicular GCT, but lacking a complete embryonal carcinoma immunophenotype.
- 6 November 2017
- Published by Wiley in Histopathology
- Vol. 72 (4) , 634-647
Germ cell tumour growth patterns originating from clear cell carcinomas of the ovary and endometrium: a comparative immunohistochemical study favouring their origin from somatic stem cells
Aims: To report a series of 11 ovarian and one endometrial neoplasm in elderly patients with mixed clear cell tumour and germ cell tumour (GCT) components, to compare their immunohistochemical profiles and demonstrate a putative stem cell population.Methods and results: The clear cell tumours included 11 clear cell carcinomas (CCC) and one borderline clear cell tumour, while the GCT always included glandular yolk sac tumour (YST). In four cases, there were also foci of teratoma with immature neuroepithelial and endodermal tissues and undifferentiated areas showing true embryoids. To distinguish between the clear cell and YST components, the following antibodies were used: HNF1‐β, napsin‐A, cytokeratin 7 (CK7), PAX8, EMA, AFP, SALL4, villin, glypican‐3 (GPC‐3), GATA3, HepPar‐1, OCT4, CDX2, CD30 and SOX2. HNF1‐β, CK7, EMA and GPC‐3 were often expressed in both components. Other markers had higher specificity for each cellular lineage; napsin‐A and PAX8 were expressed only in CCC, while SALL4, villin, AFP and HepPar‐1 were positive in the glandular YST component but negative in the clear cell component. OCT4 expression occurred in six of 10 cases and consistently in teratoma (four of four).Conclusions: There is considerable immunophenotypical overlap between the two components in these mixed neoplasms, and a panel of markers should be used to facilitate the distinction. We propose that OCT4‐expressing somatic cancer cells differentiate into GCT and represent spontaneously induced pluripotent stem cells, possibly conditioned by age‐related epigenetic factors. These neoplasms have features of prepubertal type GCT showing lack of 12p gain, preponderance of YST and coexistence with immature neuroectoderm. However, there may also be undifferentiated stem cell areas with embryoid bodies, of the type seen in postpubertal testicular GCT, but lacking a complete embryonal carcinoma immunophenotype.
- 22 September 2017
- Published by Wiley in Histopathology
- Vol. 71 (6) , 1017-1019
Microscopic tubal sex‐cord proliferations with a Sertoli cell tumour pattern and ovarian‐type stromal transformation of the fimbriae
- 22 September 2017
- Published by Wiley in Histopathology
- Vol. 71 (6) , 1017-1019
Microscopic tubal sex‐cord proliferations with a Sertoli cell tumour pattern and ovarian‐type stromal transformation of the fimbriae
- 7 March 2017
- Published by Springer Nature
- p. 131-179
Diagnostic Immunopathology of Germ Cell Tumors
- 7 March 2017
- Published by Springer Nature
- p. 397-417
Germ Cell Tumors of Miscellaneous Extragonadal Sites
- 7 March 2017
- Published by Springer Nature
- p. 397-417
Germ Cell Tumors of Miscellaneous Extragonadal Sites
- 6 September 2015
- Published by Wiley in Histopathology
- Vol. 68 (4) , 613-615
GATA binding protein 3 expression is present in primitive patterns of yolk sac tumours but is not expressed by differentiated variants
- 6 September 2015
- Published by Wiley in Histopathology
- Vol. 68 (4) , 613-615
GATA binding protein 3 expression is present in primitive patterns of yolk sac tumours but is not expressed by differentiated variants
- 19 May 2015
- Published by SAGE Publications in International Journal of Surgical Pathology
- Vol. 23 (5) , 388-392
Ovarian Small Cell Carcinoma of Pulmonary Type Arising in Mature Cystic Teratomas With Metastases to the Contralateral Ovary
A bilateral small cell ovarian carcinoma pulmonary-type (SCCOPT), arising in bilateral mature cystic teratomas (MCTs) presented as stage IIIB in a 37-year-old woman. Microscopically, tumor nests were related to the dermoid protuberance and expressed pancytokeratin, EMA, CD56, chromogranin A, NSE, synaptophysin, and SOX2. SALL4 was also focally positive. CDX2, TTF1, PAX8, CK7, CK20, and several neuroendocrine gut hormones were negative. Serum NSE was elevated. This case represents a SCCOPT arising in an MCT in the right ovary with metastasis to the left one also containing a synchronous MCT. Surface implants and lymphovascular invasion suggested metastasis from the right ovarian SCCOPT and excluded a metastatic origin from usual locations of small cell carcinoma (SCC). SCCOPT is morphologically identical to SCC elsewhere, even sharing NSE serum elevation. Although the tumor was closely related to teratomatous mature tissues, a complex immunohistochemical panel failed to provide a tissue of origin.
- 19 May 2015
- Published by SAGE Publications in International Journal of Surgical Pathology
- Vol. 23 (5) , 388-392
Ovarian Small Cell Carcinoma of Pulmonary Type Arising in Mature Cystic Teratomas With Metastases to the Contralateral Ovary
A bilateral small cell ovarian carcinoma pulmonary-type (SCCOPT), arising in bilateral mature cystic teratomas (MCTs) presented as stage IIIB in a 37-year-old woman. Microscopically, tumor nests were related to the dermoid protuberance and expressed pancytokeratin, EMA, CD56, chromogranin A, NSE, synaptophysin, and SOX2. SALL4 was also focally positive. CDX2, TTF1, PAX8, CK7, CK20, and several neuroendocrine gut hormones were negative. Serum NSE was elevated. This case represents a SCCOPT arising in an MCT in the right ovary with metastasis to the left one also containing a synchronous MCT. Surface implants and lymphovascular invasion suggested metastasis from the right ovarian SCCOPT and excluded a metastatic origin from usual locations of small cell carcinoma (SCC). SCCOPT is morphologically identical to SCC elsewhere, even sharing NSE serum elevation. Although the tumor was closely related to teratomatous mature tissues, a complex immunohistochemical panel failed to provide a tissue of origin.
- 1 May 2015
- Published by Wolters Kluwer Health in International Journal of Gynecological Pathology
- Vol. 34 (3) , 293-297
Ovarian Strumal Carcinoid Containing Appendiceal-Type Mucinous Tumor Patterns Presenting as Pseudomyxoma Peritonei
We report for the first time a case of ovarian strumal carcinoid containing both trabecular carcinoid and mucinous glands lined by both goblet and neuroendocrine cells and a low-grade mucinous neoplasm that presented clinically as pseudomyxoma peritonei in the absence of appendiceal lesion in a 58-yr-old woman. Histologically, there were both a tall columnar cell epithelial component lacking neuroendocrine cells, showing the scalloped contours and subepithelial clefts of low-grade appendiceal-type neoplasms and a mixed goblet cell neuroendocrine element. Characteristically, both reproduced appendiceal neoplastic phenotypes in a teratoid fashion. In addition, we present previously unreported oncocytic and mucinous changes in the thyroideal components of strumal carcinoid. This case represents a rare instance of pseudomyxoma peritonei of primary ovarian origin and is an example of multiple somatic teratoid endodermal differentiations of the different sections of the embryonal gut: foregut represented by thyroid, midgut by both mucinous appendiceal components, and hindgut by trabecular carcinoid.
- 1 May 2015
- Published by Wolters Kluwer Health in International Journal of Gynecological Pathology
- Vol. 34 (3) , 293-297
Ovarian Strumal Carcinoid Containing Appendiceal-Type Mucinous Tumor Patterns Presenting as Pseudomyxoma Peritonei
We report for the first time a case of ovarian strumal carcinoid containing both trabecular carcinoid and mucinous glands lined by both goblet and neuroendocrine cells and a low-grade mucinous neoplasm that presented clinically as pseudomyxoma peritonei in the absence of appendiceal lesion in a 58-yr-old woman. Histologically, there were both a tall columnar cell epithelial component lacking neuroendocrine cells, showing the scalloped contours and subepithelial clefts of low-grade appendiceal-type neoplasms and a mixed goblet cell neuroendocrine element. Characteristically, both reproduced appendiceal neoplastic phenotypes in a teratoid fashion. In addition, we present previously unreported oncocytic and mucinous changes in the thyroideal components of strumal carcinoid. This case represents a rare instance of pseudomyxoma peritonei of primary ovarian origin and is an example of multiple somatic teratoid endodermal differentiations of the different sections of the embryonal gut: foregut represented by thyroid, midgut by both mucinous appendiceal components, and hindgut by trabecular carcinoid.
- Open Access
- 1 January 2015
- Published by Elsevier in Gynecologic Oncology Reports
- Vol. 11, 13-15
Endometrial stromal nodule of the vaginal wall with a review of vulvovaginal endometrial stromal neoplasms
- 1 January 2015
- Published by Elsevier in Gynecologic Oncology Reports
- Vol. 11, 13-15
Open AccessEndometrial stromal nodule of the vaginal wall with a review of vulvovaginal endometrial stromal neoplasms
- 30 October 2014
- Published by Wiley in Histopathology
- Vol. 65 (6) , 923-925
Papillary ependymoma of the endometrium
To report an exceptional case of papillary ependymoma occurring in the endometrium. A clinicopathological study was performed regarding a case of papillary ependymoma occurring in the endometrial cavity of a 61-year-old patient who had presented with a solid-type, stage III anaplastic ependymoma of the ovary, treated with cytoreductive surgery that included total abdominal hysterectomy. The uterus was enlarged and showed a dilated cavity, with broadly implanted papillary excrescences without myometrial invasion that were covered by tall, cylindrical cells. These cells had glial fibrillary acidic protein-expressing cytoplasm that was also positive for cytokeratins 7, 8, 18, and 34β-E12, epithelial membrane antigen, S100 protein, vimentin, and oestrogen and progesterone receptors. Pathogenetically, the presence of this uterine ependymoma could represent either an example of multicentricity or a phenomenon of transtubal implantation of the ovarian tumour. Exceptionally, papillary ependymoma can occur in the endometrium, and may prompt differential diagnoses with other papillary endometrial tumours. Pathologists should consider this rare possibility in the differential diagnosis of papillary ovarian and endometrial lesions.
- 30 October 2014
- Published by Wiley in Histopathology
- Vol. 65 (6) , 923-925
Papillary ependymoma of the endometrium
To report an exceptional case of papillary ependymoma occurring in the endometrium. A clinicopathological study was performed regarding a case of papillary ependymoma occurring in the endometrial cavity of a 61-year-old patient who had presented with a solid-type, stage III anaplastic ependymoma of the ovary, treated with cytoreductive surgery that included total abdominal hysterectomy. The uterus was enlarged and showed a dilated cavity, with broadly implanted papillary excrescences without myometrial invasion that were covered by tall, cylindrical cells. These cells had glial fibrillary acidic protein-expressing cytoplasm that was also positive for cytokeratins 7, 8, 18, and 34β-E12, epithelial membrane antigen, S100 protein, vimentin, and oestrogen and progesterone receptors. Pathogenetically, the presence of this uterine ependymoma could represent either an example of multicentricity or a phenomenon of transtubal implantation of the ovarian tumour. Exceptionally, papillary ependymoma can occur in the endometrium, and may prompt differential diagnoses with other papillary endometrial tumours. Pathologists should consider this rare possibility in the differential diagnosis of papillary ovarian and endometrial lesions.